Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWilmington Regulatory News (WIL)

Share Price Information for Wilmington (WIL)

Share Price is delayed by 15 minutes
Get Live Data
260.00    0.00 (0.00%)
Bid:
256.00
Ask:
265.00
Spread: 9.00 (3.516%)
Market Cap: £232.84m
WIL Live PriceLast checked at - London Stock Exchange

Intraday Wilmington Share Chart

Trading Statement

23 Jul 2025 07:00

RNS Number : 1038S
Wilmington PLC
23 July 2025
 

23 July 2025

Wilmington plc

 

Year-end trading update

 

Wilmington plc, (LSE: WIL, 'Wilmington', 'the Group') the provider of data, information, education and training in the global Governance, Risk and Compliance ('GRC') markets, today provides a trading update for the year ended 30 June 2025.

 

Revenue growth from the Group's ongoing* businesses is expected to be 11%, led by both recent acquisitions in the HSE sector delivering double-digit percentage growth.

 

As at the half year, seven out of nine businesses grew year on year. Following the portfolio changes last year of two disposals and two acquisitions, and the continuing disruption in the US healthcare insurance market impacting our US events business over a full year, reported revenue is expected to be £101.5m (2024: £126m), with organic** revenue also having decreased 1% due to the US.

 

Operating profit from ongoing* businesses is expected to be up 11%, adjusted*** profit before tax is expected to be £27.7m (2024: £27.6m), with adjusted PBT margin up to 27% (2024: 22%).

 

Cash conversion continued to be strong at 107% of profits, with Group net cash on 30 June 2025 at £41.9m (30 June 2024: £67.8m) after the completion of the acquisition of Phoenix Health & Safety on 25 October 2024 and spending £3.4m on share buybacks.

 

Wilmington expects to publish its year end results on 22 September 2025.

 

Mark Milner, Chief Executive Officer, commented:

 

"We have seen another year of good ongoing* revenue and profit growth with both measures increasing 11%, reflecting our focus on a slimmed down higher quality portfolio of growing businesses. Margins have also continued to improve and both of our recent acquisitions have seen double digit growth. This performance came against a tough macro backdrop, particularly in the US healthcare market which has seen continued disruption in the course of our H2.

 

"With the acquisition of Phoenix, we have continued to actively manage our portfolio of businesses and are pursuing various opportunities to invest our cash in acquisitions to improve the quality of revenue and profits."

 

*Ongoing - eliminating the effects of the impact of disposals, closures and businesses held for sale.

**Organic - Ongoing, eliminating acquisitions and exchange rate fluctuations

***Adjusted profit before tax (PBT) is calculated as PBT after adding back amortisation and impairment of intangible assets (except computer software) and profits/losses on disposals and business closures. Market consensus adjusted profit before tax is £27.0m.

 

For further information, please contact:

 

Wilmington plc

Mark Milner, Chief Executive Officer

Guy Millward, Chief Financial Officer

 

Meare Consulting

Adrian Duffield

 

 

020 7490 0049

 

 

 

 

07990 858548

 

The information contained within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014. Upon the publication of this announcement this inside information is now considered to be in the public domain.

 

Notes to Editors

Wilmington plc is the recognised knowledge leader and partner of choice for data, information, education and training in the global Governance, Risk and Compliance (GRC) markets. Wilmington employs around 600 people and sells to around 120 countries. Wilmington is listed on the main market of the London Stock Exchange.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTUUUORVWUBUAR
Date   Source Headline
8th Jul 20193:54 pmRNSHolding(s) in Company
4th Jul 20197:00 amRNSExtension of debt facility
1st Jul 20195:11 pmRNSTotal Voting Rights
28th Jun 20197:00 amRNSWilmington plc Pre-close Trading Update
10th Jun 20194:41 pmRNSSecond Price Monitoring Extn
10th Jun 20194:35 pmRNSPrice Monitoring Extension
3rd Jun 20197:00 amRNSTotal Voting Rights
17th May 201912:13 pmRNSHolding(s) in Company
17th May 20199:21 amRNSHolding(s) in Company
16th May 20197:00 amRNSAppointment of Mark Milner as CEO
8th May 20197:00 amRNSChange of Company Secretary
3rd May 201911:18 amRNSDirector Declaration
1st May 20197:00 amRNSTotal Voting Rights
2nd Apr 20192:20 pmRNSTotal Voting Rights
1st Apr 20197:00 amRNSSAYE and Director/PDMR Shareholding
1st Mar 201911:00 amRNSHolding(s) in Company
1st Mar 201910:58 amRNSTotal Voting Rights
21st Feb 20197:00 amRNSResults for the six months ended 31 December 2018
14th Feb 201910:19 amRNSDirectorate Change Update
1st Feb 20193:53 pmRNSTotal Voting Rights
28th Jan 20194:44 pmRNSHolding(s) in Company
16th Jan 20197:00 amRNSDirectorate Change
2nd Jan 201910:33 amRNSTotal Voting Rights
14th Dec 20184:43 pmRNSNotification of Interim Results
3rd Dec 20187:00 amRNSTotal Voting Rights
14th Nov 20187:00 amRNSNew Joint Venture Agreement
1st Nov 20182:07 pmRNSResult of AGM
1st Nov 20187:00 amRNSAGM Statement and Q1 Trading Update
1st Nov 20187:00 amRNSTotal Voting Rights
17th Oct 20185:13 pmRNSHolding(s) in Company
1st Oct 20185:44 pmRNSDirector/PDMR Shareholding
1st Oct 201810:18 amRNSTotal Voting Rights
25th Sep 201812:29 pmRNSHolding(s) in Company
21st Sep 20183:13 pmRNSDirector/PDMR Shareholding
20th Sep 20183:19 pmRNSDirector/PDMR Shareholding
19th Sep 20182:12 pmRNSShare Awards
12th Sep 20187:00 amRNSFinancial results for the year ended 30 June 2018
3rd Sep 20189:00 amRNSTotal Voting Rights
28th Aug 201810:39 amRNSHolding(s) in Company
1st Aug 20189:00 amRNSTotal Voting Rights
19th Jul 20187:00 amRNSSale of ICP Credit Reporting Business
10th Jul 20184:24 pmRNSHolding(s) in Company
10th Jul 20184:19 pmRNSHolding(s) in Company
9th Jul 20182:23 pmRNSHolding(s) in Company
6th Jul 20187:00 amRNSTrading Statement
2nd Jul 201810:29 amRNSVoting Rights and Capital
1st Jun 20189:00 amRNSTotal Voting Rights
9th May 20187:00 amRNSCapital Markets Day
1st May 20187:00 amRNSTotal Voting Rights
3rd Apr 20187:00 amRNSVoting Rights and Capital

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.